Efficacy and tolerability of trabectedin in elderly patients with sarcoma: Subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma

R. L. Jones, G. D. Demetri, S. M. Schuetze, M. Milhem, A. Elias, B. A. Van Tine, J. Hamm, S. McCarthy, G. Wang, T. Parekh, R. Knoblauch, M. L. Hensley, R. G. Maki, S. Patel, M. Von Mehren

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and tolerability of trabectedin in elderly patients with sarcoma: Subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma'. Together they form a unique fingerprint.

Medicine & Life Sciences